17 results
8-K
ADIL
Adial Pharmaceuticals Inc
23 Aug 22
Departure of Directors or Certain Officers
6:02am
committee, and a director of ForzaX1, Inc., a Nasdaq-listed developer of electric sport boats with a mission to inspire the adoption of sustainable
8-K
EX-99.1
3kf 9c7mspi1ub
20 Jul 22
Adial Pharmaceuticals Announces Topline Results for Onward™ Phase 3 Trial
7:14am
POS AM
s9j1ov5vh2ordkaxox5
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
POS AM
9k6j7503
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm
8-K
EX-99.1
fzarek ib2h9
9 Dec 21
Adial Announces Cary J. Claiborne, a Renowned Pharmaceutical Executive and Current Board Member, has Joined the Company as Chief Operating Officer
9:29am
8-K
EX-99.1
5bbavibrqmt fe
16 Jul 21
Adial Announces Positive Pre-Clinical Data for its Adenosine Pain Platform
9:20am
8-K
EX-99.1
ltck 30qnp
1 Feb 21
Adial Pharmaceuticals Closes Acquisition of Purnovate
5:27pm
8-K
EX-10.1
0rgexfr
17 Dec 20
Entry into a Material Definitive Agreement
5:09pm
8-K
EX-99.1
k520mvmad3xxvhc
10 Dec 20
Entry into a Material Definitive Agreement
9:45am
8-K
o0d5fa
10 Dec 20
Entry into a Material Definitive Agreement
9:45am
8-K/A
EX-99.1
b0rdz3
25 Jan 19
Adial Pharmaceuticals Receives $1.2 Million in Proceeds Through the Exercise of Warrants
4:32pm
8-K
EX-99.1
ky7gby0 f9rvwh81
24 Jan 19
Adial Pharmaceuticals Receives $1.2 Million in Proceeds Through the Exercise of Warrants
9:59pm
- Prev
- 1
- Next